Chungui International BioTech Group is a small, early-stage Chinese health products company built around a single product: a fermented cinnamon wine marketed as a functional health beverage. The company sources a specific cinnamon variety called Liuchen Yugui from Pingnan County, Guangxi, and converts it into what it positions as a traditional Chinese medicine-inspired functional drink using a proprietary microbial fermentation process called the "Microbial Fan's Method." Chungui sells bottled product directly to consumers and through a distributor and agent network, with channels including chain pharmacies, health management centers, high-end dining establishments, and e-commerce. Revenue is recognized at point of sale. As of its IPO filing, the company had just 22 full-time employees, a single production facility in Guangxi, and minimal revenues. The company raised approximately $13M in IPO proceeds, which it intends to allocate toward R&D, production capacity expansion, brand building, and international expansion. Chungui's near-term focus is on deepening penetration in China, while building the regulatory certifications needed to eventually sell in North America, Southeast Asia, and Europe. The company argues its differentiation rests on its proprietary fermentation technology, which it has protected with eight patents, and the premium positioning of its regionally sourced cinnamon ingredient.